Adaptive radiation planning using FMISO imaging for head and neck cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests a way to personalize radiation treatment using a special scan (FMISO) to improve targeting in certain head and neck cancers. It is designed for people who are newly diagnosed and ready for standard curative (definitive) chemoradiation or faster radiation schedules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of a specific head and neck squamous cell cancer: larynx, hypopharynx, or mouth (oral cavity), or oropharynx that is p16-negative
- Your cancer is stage III or IV but only in the head/neck area (no distant spread)
- You need to be eligible for curative treatment with chemoradiation or a faster, higher-frequency radiation schedule
- Your general health (ECOG) is 0 or 1, meaning you can do most daily activities
- Your blood/organ tests show kidney and liver function are adequate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
This study tests whether giving lower doses of radiation and chemotherapy is safe and effective for people with certain head and neck cancers. It aims to reduce side effects while keeping the treatment successful.
This study uses a special MRI scan to measure oxygen levels in your head and neck tumor. The goal is to learn if this scan can help doctors choose the best treatment plan for you.
This trial is studying how MRI images can help predict response to a combination of chemotherapy and immunotherapy before surgery for head and neck cancer. It aims to improve treatment planning for patients with this type of cancer.
This Phase 2 trial tests whether planning radiation based on an imaging scan (F-MISO PET) can better target oxygen-poor (low-oxygen) tumor areas in head and neck cancer. It may help make radiation more precise while still using standard curative treatment.
This trial uses a special PET scan tracer called 18F-FMISO to see areas of low oxygen (hypoxia) in your tumor. The results may help doctors adjust your radiation plan to target those areas more precisely.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.